CClinicalTrials.gg
CompletedNCT07398625Updated Feb 10, 2026

Management of Cesarean Section Scar Ectopic Pregnancy: Sohag University Experience

An observational study in CS Scar Pregnancy, sponsored by Sohag University. Completed at 1 site in Egypt. Open to female participants aged 18 Years to 40 Years. Per ClinicalTrials.gov, last updated 2026-02-10.

Sponsored by Sohag University · Observational

Study type
Observational
Model
Cohort
Time perspective
Cross-sectional
Enrollment
37
Ages
18 Years to 40 Years
Sex
Female
01

Study summary

management of CS scar ectopic pregnancy

02

Conditions studied

  • CS Scar Pregnancy
03

In context

Lead sponsor

Sohag University is the lead sponsor of 1,183 studies on the registry; 612 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 40 Years
Sexes eligible
Female
Accepts healthy volunteers
No
Sampling method
Probability sample

Study population

1st trimester pregnancy (6-10) weeks Age: (18-40) years All types of scar ectopic pregnancy endophytic and exophytic types Viable and non-viable scar ectopic.

Inclusion criteria

1st trimester pregnancy (6-10) weeks Age: (18-40) years All types of scar ectopic pregnancy endophytic and exophytic types Viable and non-viable scar ectopic.

Exclusion criteria

Exclusion Criteria:

Patients with serious systemic diseases will be excluded, such as; heart disease, thrombocytopenia, bronchial asthma and systemic lupus erythematosus because these conditions may affect treatment options and efficacy.

05

Study design

Observational model
Cohort
Time perspective
Cross-sectional
Enrollment
37 participants (actual)
Patient registry
No

Interventions

  • OtherObservation

    observation of cs scar pregnancy cases \&their management in Sohag University

06

What researchers measure

Primary outcomes

  1. irregular uterine bleeding and hematoma formation after surgical evacuation

    Time frame: 18 months

07

Study locations

1 site
  • Sohag University
    Sohag, Egypt
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Feb 10, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07398625
Lead sponsor
Sohag University
Responsible party
Reem Kamel lotfy (Sohag, Sohag University) — Principal investigator
First posted
Feb 10, 2026
Start date
Jan 1, 2024
Primary completion
Dec 1, 2025
Completion
Dec 1, 2025
Last update
Feb 10, 2026

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Feb 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion